NKMax America Revenue and Competitors
Estimated Revenue & Valuation
- NKMax America's estimated annual revenue is currently $13.9M per year.
- NKMax America's estimated revenue per employee is $155,000
- NKMax America's total funding is $11M.
Employee Data
- NKMax America has 90 Employees.
- NKMax America grew their employee count by -5% last year.
NKMax America's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CTO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | VP Marketing | Reveal Email/Phone |
4 | Director, Regulatory Affairs | Reveal Email/Phone |
5 | Laboratory Purchasing and Facilities Manager | Reveal Email/Phone |
6 | Senior Engagement Manager | Reveal Email/Phone |
NKMax America Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is NKMax America?
NKMax America is harnessing the power of the body's immune system through the development of unique Natural Killer (NK) cell therapies. NK cell adoptive immunotherapy enhances a patient's ability to destroy abnormal cells. The mission of NKMax is to improve patients' lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics. More information can be found on our website www.nkmaxamerica.com
keywords:N/A
$11M
Total Funding
90
Number of Employees
$13.9M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Santa Ana
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 90 | 8% | N/A |
#2 | $7.5M | 90 | 7% | N/A |
#3 | $22.1M | 90 | 0% | N/A |
#4 | $25.9M | 96 | 16% | N/A |
#5 | $14.6M | 97 | 17% | N/A |